(Senior) HTA-Statistiker (all genders)

The assessment of additional benefits by the Gemeinsamer Bundesausschuss (G-BA) is at the beginning of the marketing of new drugs. As a manufacturer, AbbVie must submit a benefit dossier, and this is where you come in. You will be responsible for the statistical strategy for our drugs in the context of benefit dossiers for the AMNOG process. You plan an HTA strategy and create local analysis plans, review and interpret the results of clinical trial evaluations (subpopulations, subgroups, heterogeneity tests), meta-analyses, and indirect comparisons for the early benefit assessment of drugs according to §35a SGB V (“AMNOG”). You support the biometric assessment of studies regarding their methodological quality and the creation of study protocols, taking into account the methodological requirements of our German institutions. You represent AbbVie at consultations and hearings with the Gemeinsamer Bundesausschuss.